Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Efficacy, safety, and immunogenicity of recombinant insulin aspart (BioGenomics Limited) and NovoRapid® (Novo Nordisk) in adults with type 2 diabetes mellitus: a randomized, open-label, multicenter, phase-3 study.
Res Pharm Sci. 2024 Oct 22;19(5):489-499. doi: 10.4103/RPS.RPS_188_23. eCollection 2024 Oct.
Res Pharm Sci. 2024.
PMID: 39691304
Free PMC article.
In Vitro Biological Characterization of Recombinant Insulin Aspart from Biogenomics and Originator Insulin Aspart.
Mishra AG, Deshmane RB, Thappa DK, Lona J, Ghade NS, Sonar SM, Krishnan AR.
Mishra AG, et al. Among authors: deshmane rb.
BioDrugs. 2023 Sep;37(5):709-719. doi: 10.1007/s40259-023-00607-4. Epub 2023 Jun 7.
BioDrugs. 2023.
PMID: 37285012
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.